What are 5-HT4 receptor agonist drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

5-HT4 receptor agonist drugs are pharmacologic agents that share a common mechanism (typically targeting 5-HT4 receptor). 0 are currently marketed, with 2 more in clinical development.

5-HT4 receptor agonist

0 marketed 2 in Phase 3

This page covers all 5-HT4 receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT4 receptor.

Targets

5-HT4 receptor

Phase 3 pipeline (2)

OPN-375 · Optinose US Inc. · Gastroenterology
OPN-375 is a selective serotonin 5-HT4 receptor agonist that enhances gastric motility and accelerates gastric emptying.
Mosapride Citrate Tablets · Xiyuan Hospital of China Academy of Chinese Medical Sciences · Gastroenterology
Mosapride citrate is a 5-HT4 receptor agonist that enhances gastric motility and accelerates gastric emptying.

Patent intelligence

5 ht4 receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates